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Outline
• IMM Overview
• International Space Station Probabilistic Risk 
Assessment Update
• Validation
• Optimization
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4IMM Project Goals
• To develop an integrated, quantified, evidence-
based decision support tool useful to NASA 
crew health and mission planners.
• To help align science, technology, and 
operational activities intended to optimize crew 
health, safety, and mission success.
5What is IMM?
• A software-based decision support tool 
• Forecasts the impact of medical events on 
space flight missions
• Optimizes the medical system within the 
constraints of the space flight environment 
during simulations.
6Scope and Approach
• Scope
• Forecast medical outcomes for in-flight operations only
• Forecast medical impacts to mission
• Does not assess long-term or chronic post-mission 
medical consequences
• Approach
• Use ISS data as stepping stone to Exploration Program
• Employ best-evidence clinical research methods
• Employ Probability Risk Assessment (PRA) techniques
• Collaborate with other NASA Centers and Organizations
IMM addresses in-flight risk using ISS data as a stepping stone
7“What if…?” Questions
• Questions
• Is the current ISS medical kit adequate for a crew of 6 on a 
6-month mission?
• Does a 33-day lunar sortie mission require a different Level 
of Care than a 24-day lunar sortie mission?
• Are we carrying enough Ibuprofen for a crew of six on a 12-
month mission?
• How does risk change if the ventilator fails at the start of a 3-
year mission?
• Questions
• What is the probability of a bone fracture occurring 10 years 
after a 6-month mission?
• What is the probability of renal stone formation after a 12-
month mission?
IMM is designed to help answer specific in-flight questions
8Risk and Risk Components
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“Risk” is what  is left over after you have accounted for 
likelihood, outcome, and the mitigation associated with the threat. 
9Comparison – 5x5 Risk Matrix vs. IMM
Integrated
Medical
Model
Medical Conditions & 
Incidence Data
Crew Profile
Mission Profile & Constraints
Crew Functional 
Impairments
 In-flight Medical Resources
Medical Condition Occurrences
Crew Impairment
Clinical/Mission End States
Resource Utilization
Optimization of Vehicle 
Constraints and Medical 
System Capabilities
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• Categorical
• Subjective
• Single Risk
• No Uncertainty
• No Confidence Interval
• Limited context
• Quantitative
• Probabilistic, Stochastic
• Evidence-based
• Integrated Risks
• Uncertainty
• Confidence Interval
• In context
5x5 Matrix IMM
Risk
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IMM Conceptual Model
INPUTS
 Medical 
Conditions & 
Incidence Data
 Crew Profile
 Mission Profile & 
Constraints
 Potential Crew 
Impairments
 Potential Mission 
End states
 In-flight Medical 
Resources
Integrated
Medical
Model
OUTPUTS
 Medical Condition 
Occurrences
 Crew Impairments
 Clinical End States
 Mission End States
 Resource Utilization
 Optimized Medical 
System
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IMM Logic - Event Sequence Diagram
Medical 
Event
Treated case: 
Decrement 
medical 
resources
Yes
Untreated Worst 
Case
No
Untreated      
Best Case
No
Worst-case 
resources 
available?
Worst-case Scenario
Best-case 
resources 
available?
Treated case: 
Decrement 
medical 
resources
Calculate End 
States:
• Evacuation (EVAC)
• Loss of Crew Life    
(LOCL)
• Crew Functional 
Impairment
• Type and Quantity of 
Medical  Events 
(organized by Medical, 
Injury, or 
Environmental 
categories)
• Resource Utilization 
and Depletion
Yes
Best-case Scenario
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IMM Logic
• Did the medical condition happen?
• How many times?
• Best- or worst-case scenario?
• Were resources available?
• What was the outcome?
1
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For each comparative assessment, the identical questions 
are asked 10,000+ times to develop outcome distributions
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Clinical Findings Form (CliFF)
Standardized Format for IMM Clinical Inputs
• The likelihood of occurrence of the medical condition
• Incidence proportion or incidence rate
• The clinical outcomes of the medical condition
• Considers ISS-based best-case, worst-case, and untreated 
case scenarios
• Specifies functional impairments and duration times
• Specifies potential end states (evacuation, loss of crew life)
• Specifies levels of evidence for input data
• References sources of data
• Medical Resource Tables
• Specifies the resources required to diagnose and treat best-
and worst-case scenarios
14
Resource Tables
• Specify resources required 
for diagnosis and treatment
• Consider the  best-case and 
worst-case scenarios
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in-flight medical resources
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Best and Worst Cases
Consumable
Disorder: 
Musculoskeletal
Description Quantity
Power 
(W)
Cost 
Estimates
 COTS 
Flight 
Certify
Sustaining 
Eng
1
Sprain/Strain 
Extremities
Ace Bandage 1 0.03875 38.75 442.5 442500  $       3.08 
SAM splint 1 0.1134 113.4 1336.3575 1336357.5  $     12.00 
1 Acetaminophen 2 0.00036 0.36 0.02632 26.32  $       0.10 
1 Ibuprofen 1-9 0.00066 0.66 0.04202 42.02  $       0.14 
        Mass
   Kg           Gm
          Volume 
       cc3          mm3
Mass
Kg    M
Volume
c3              mm3
Consumable COTSQuantity
Consumable Disorder Description Quantity Power
Cost 
Estimates 
 COTS 
Flight 
Certify
Sustaining 
Eng
Sprain/Strain 
Extremities Ace Bandage 1 0.03875 38.75 442.5000 442500  $       3.08 
SAM splint 1 0.1134 113.4 1336.3575 1336357.5  $     12.00 
1
acetaminophen (2 tabs*4-
6hr) 8 0.00036 0.36 0.0263 26.32  $       0.10 
1 ibuprofen (1-2 tabs*8hr) 10 0.00066 0.66 0.0420 42.02  $       0.14 
1 Vicodin (1-2 tabs *4-6 hr) 2 0.00064 0.64 0.0483 48.30 0.50$        
1 Gauze Pads 4 0.00504 5.04 7.6000 7600.00 0.16$        
1 Nonsterile Gloves pr 1 0.014 14 3.1000 3100 0.10$        
Sharps container 1 0.59553 595.53 2909.1250 2909125.00 817.06$      
1 20 G catheter 2 0.00622 18.51 7.5000 7500 0.15$        
1 10cc syringe 1 0.01123 11.23 4.1700 4170 0.15$        
1 Y-type catheter 1 0.00868 8.68 0.1000 100.00 0.50$        
1 Tegaderm Dressing 1 0.00252 2.52 108.2000 108200 0.38$        
1 Saline, 500mL 1 0.48929 489.29 750.8390 750839.00 10.81$      
1 Iodine Pads 1 0.00108 1.08 0.1500 150.00 0.04$        
1 Alcohol Pads 12 0.00108 1.08 0.1500 150.00 0.02$        
1 Tourniquet 1 0.00603 6.03 5.0000 5000 0.24$        
1 Tape 0.1 0.00906 9.06 6.4220 6422.00 0.11$        
1 Morphine  1-10ml 0.00795 7.95 6.8855 6885.53  $     21.50 
1 carpuject 1 0.01524 15.24 5.6267 5626.67 5.01$        
Mass
Kg            Gm
Volume 
cc3          mm3
Best-Case Scenario
Worst-Case Scenario
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Crew Health Index (CHI) 
• Quality-Adjusted Mission Time
• Modification of quality-adjusted life years 
(QALY)
• Standard epidemiologic measure
• Single, weighted measure of the net change 
in quality time
17
Example of QALY
• Consider the following individual:
• 35 years old
• 75-year life expectancy
• Medical event results in 30% functional impairment
• Below knee amputation
• What is the QALY?
• With respect to IMM, “life years” is mission time
%70%100
40
28
yrs 2812403.04040
PQALY
QALY Crew Health 
Index (CHI)
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Crew Health Index (CHI)
Measure of crew health based on 
functional impairment
• Ranges from 0 to 100%
• 0% - completely impaired due to medical 
conditions for duration of mission
• 100% - no impairment due to medical 
conditions
19
Summary
• IMM is an evidence-based decision support tool that 
can be used for risk assessment and mission 
planning
• IMM forecasts the impact of in-flight medical events 
on space flight missions
• IMM inputs include 83 medical conditions, incidence 
values, functional impairments, potential end-states 
(EVAC, LOCL) and required medical resources
• IMM outputs include EVAC, LOCL, CHI, and 
resource utilization
• IMM can be used to optimize the medical system 
within the constraints of the space flight environment 
ISS PRA Update using IMM
• Purpose
• To update medical risk forecasts of evacuation 
(EVAC) and loss of crew life (LOCL) for ISS
• Justification
• Current medical risk data and approach were 
developed over 12 years ago, use broad 
assumptions, and only address a subset of medical 
conditions relevant to the current mission profile
• Risk of EVAC and LOC due to medical events will 
be underreported
• Updated crew health risk estimates help prioritize 
medical system capabilities
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Background - ISS Risk Model 
• Probability Risk Assessment (PRA) 
methods required by ISS Program (per NPR 
8705.5)
• Current Approach for Medical Risk
• Based on pre-ISS operations evidence (1997)
• Medical conditions organized by 9 categories
• Only „severe‟ medical conditions addressed
• Assumes medical resources available > 98%
• Assumes positive clinical outcomes > 75%
21
IMM Evidence Base
• Astronaut Health Database
• ISS Expeditions 1 thru 13 (2006)
• STS-01 thru STS-114 (2005)
• Apollo, Skylab, Mir (U.S. crew only)
• Analog, terrestrial data
• Review of crew medical charts
• Flight Surgeon Subject Matter Expertise
• Russian medical data not used
22
ISS PRA Update - Methods 
• Reference Mission (as defined by ISS PRA Group)
• 6-person crew (1 female, 5 males)
• 6-month mission 
• 3 EVAs total for mission
• 83 medical conditions
• Industry standard statistical software, SAS 9.1
• SQL Database manages all clinical inputs
• Monte Carlo Simulations
• Fully treated medical with ISS medical system
• In-flight ISS Resource Utilization 
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Results
Category EVAC EVAC (%) 95% CI
Medical Illness 1 in 32 3.14 2.97-3.32
Injury/Trauma 1 in 169 0.59 0.52-0.67
Environmental 1 in 135 0.74 0.65-0.81
All Conditions 1 in 23 4.43 4.25-4.61
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ISS Reference Mission  - Fully Treated
Category LOC LOC (%) 95% CI
Medical Illness 1 in 270 0.37 0.31-0.43
Injury/Trauma 1 in 769 0.13 0.10-0.16
Environmental 1 in 172 0.58 0.49-0.65
All Conditions 1 in 94 1.06 0.97-1.16
Conversion of % EVAC to events/person-yr
• IMM forecasts a 4.43% probability of EVAC for a 
6-crew/6-month ISS mission
• 6 crew x  0.5 years (6 months) = 3 person-yrs
• 0.0443  events/3 person-yrs = 0.015 events/person-yr
• IMM forecasts a 1.06% probability of LOCL for a 
6-crew/6-month ISS mission
• 6 crew x 0.5 years (6 months) = 3 person-yrs
• 0.0106 events/3 person-yrs = 0.0035 events/person-yr
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Comparison of Risk of EVAC Rates
Source Low 
(events/person-yr)
Max
(events/person-yr)
IMM (mean) 0.015 -
ISS PRA (mean) 0.001 -
ISS Independent Safety Task 
Force (February 2007)
0.028 0.042
Terrestrial General Population 0.060 -
Antarctic Population 0.036 -
U.S. Submarine Population 0.023 0.028
Russian Historical Space Flight 
Data
0.032 0.072
LSAH (Astronaut Health) Data 0.010 0.020
SSF Clinical Experts Seminar 
Proceedings (1990)
0.010 0.030
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IMM forecasted Risk of EVAC rates compare favorably with 
literature review EVAC rates (0.010 to 0.072)
Validation - Risk of EVAC
IMM Simulation Data
Medical illness (71%)
1. Dental Abscess
2. Sepsis
3. Kidney Stones
4. Stroke
5. Atrial Fibrillation
6. Acute Chest Pain/Angina
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Injury/Trauma (13%)
1. Hypovolemic Shock
2. Wrist Fracture
Environmental (16%)
1. Smoke Inhalation
2. Toxic Exposure
Actual Russian Flight Data
Three EVACs 
1. Urosepsis
2. Cardiac Arrhythmia
3. Smoke Inhalation
Three Close Call EVACs
1. Kidney Stone
2. Dental Abscess
3. Toxic Exposure
NOTE:  No Russian data are in the IMM
Validation – Risk of LOCL forecast
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Source LOC (events/person-yr)
IMM 
(6-crew/6-month mission)
0.0035
ISS PRA
(3-crew/6-month mission)
0.0006
Terrestrial Mortality Rate 0.0081 (2006)
48-year old male 0.0047 (2006)
48-year old female 0.0028 (2006)
Antarctic 0.0054 (1904-1964)
LSAH Data 0.0054 (1959-1991)
IMM forecasted Risk of LOC rates compare favorably with 
literature review results for LOC rates (0.0028 to 0.0081)
Summary of Validation
Source Low 
(events/person-year)
Max 
(events/person-year)
IMM (mean) 0.015 -
ISS PRA (mean) 0.001 -
Evidence-based 
Literature
0.010 0.072
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Source Low 
(events/person-year)
Max 
(events/person-year)
IMM (mean) 0.0035 -
ISS PRA (mean) 0.0006 -
Evidence-based 
Literature
0.0028 0.0081
Risk of Evacuation (EVAC) Estimates
Risk of Loss of Crew Life (LOCL) Estimates
Comparison of Data – IMM vs. ISS PRA
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Source Model Risk of EVAC* Risk of LOC* 
IMM (mean) 0.015 (4.43%) 0.0035 (1.06%)
ISS PRA (mean) 0.001 (0.35%) 0.0006 (0.17%)
Difference x15 factor x5.8 factor
* Shown as events/person-year, and percent during mission
Summary of ISS PRA Update
• Medical events will be lead contributor to “Risk of 
EVAC/LOC”, surpassing ISS PRA estimates of “Risk of 
EVAC/LOC” from MMOD
• A comprehensive evidence review forms the basis for 
updating the ISS PRA Risk Model
• Presented to and accepted by the ISS Program Office in 
December, 2010
31
32
IMM Validation - Background
• The IMM is expected to be a significant contributor to 
medical decision making in operational and planning 
processes for space flight missions
• NASA Standard 7009  requires that real world events 
be accurately represented by the model results to 
reach sufficient levels of validation
• For the IMM, this requirement is partially fulfilled by 
comparing the model‟s predicted outcomes with 
observed mission data that have not been included in 
the model
Validation
• Model Validation
• “Substantiation that a computerized model within 
its domain of applicability possesses a satisfactory 
range of accuracy consistent with the intended 
application of the model”
• Schlesinger  et al. Terminology for model credibility. 
Simulation. 32 (3): 103-104
• Historical Data Validation
• “If historical data exist, part of the data is used to 
build the model and the remaining data are used to 
determine (test) whether the model behaves as the 
system does”
• Sargent. Verification and Validation of Simulation Models. 
Proceedings of the 2007 Winter Simulation Conference
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Data Analysis
• Data on historical space flight missions were 
collected from mission medical records
• Data available for comparison included
• Total number of medical events
• The number of occurrences of each medical event
• Medical resource utilization
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Validation Approach
• Qualitative and quantitative approaches 
were used to compare historical data to 
model output
• Qualitative Approach
• Plots were created to visualize the differences 
between the model  and historical data
• Quantitative Approach
• Goodness of Fit (GoF) testing was chosen to 
test the null hypothesis that the predicted 
outcomes are statistically equivalent to the 
observed data
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Methods
Simulation
• Model was run for seven ISS missions and fourteen 
Shuttle missions *
• Mission and crew profile were matched to historical 
mission data [# of crew, sex, mission length, and 
number of extravehicular activities (EVAs)]
• Each simulation was executed for 20,000 trials
* Data from these missions have not been used as inputs for 
the model
Results
Total Medical Events - ISS Missions
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Mission Expected Observed Difference
1 12 7 5
2 18 14 4
3 18 13 5
4 14 10 4
5 15 14 1
6 17 16 1
7 19 23 -4
Average 16 14 2
Results
Spider Plot for ISS Missions
Total Number of Medical Events by Crewmember
p = 0.36
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Results – Total Medical Events – Shuttle Missions
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Mission # of Crew Expected Observed Difference
1 6 24 26 -2
2 6 24 25 -1
3 6 24 22 2
4 7 28 27 1
5 6 25 31 -6
6 5 20 23 -3
7 6 26 28 -2
8 6 25 21 4
9 5 21 20 1
10 6 26 19 7
11 6 24 23 1
12 6 23 19 4
13 6 25 32 -8
14 6 24 21 3
Average 6 24 24 0
Results
Spider Plot for Shuttle Missions
Total Number of Medical Events by Mission
p = 0.83
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Expected
Observed
Summary of Results
• Total Medical Events
• There was no significant difference between the 
total number of medical events forecasted by IMM 
and the total number of medical events observed 
on missions
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Optimization 
• Optimize medical kit using IMM results
• Specific mission and crew profile
• Approaches
1) Maximize outcome given resource constraints
2) Minimize resources given desired outcome(s)
42
http://spaceflight.nasa.gov/gallery/images/shuttle/sts-133/html/sts133-s-002.html
Approaches
1) Maximize (or Minimize) outcomes
• What can we fit in the box?
• Resource constraints must be satisfied
2) Minimize resources
• How big of a box do you need?
• Outcome constraints must be satisfied
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Resource Constraints
• Multiple constraints on medical resources
• Mass
• Volume
• Cost
• Packaging
• Bandwidth
• Power
• Etc.
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Define Constraints and Outcomes
• Define resource constraints
• Maximum mass
• Maximum volume
• Decide which outcome(s) are of interest
• Maximize CHI
• Minimize Pr(EVAC)
• Fill medical kit with the most efficient set of 
medical resources
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Example
• Number of crew members
• 4 (2M, 2F)
• Mission Length
• 24 days
• Maximize CHI
• Resource constraints
• 4.3 kg
• 6421.7 cm3
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http://www.nasa.gov/multimedia/imagegallery/iotd.html#
Results (24 days, 4 crew)
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Medical Kit
Parameter Optimum Maximum
Mass (kg) 4.11 67.3
Volume (cm3) 6421.7 188602.8
Mean CHI (%) 94.7 95.2
EVAC (%) 6.41 0.43
LOCL (%) 0.19 0.10
• Resource constraints
• 4.3 kg
• 6421.7 cm3
Minimizing Resources
• Define outcome(s), constraints
• Pr(EVAC) ≤ 2%
• Mean CHI ≥ 90%
• Identify sets of conditions that should be 
treated to satisfy the constraints
• Identify the minimum such set
48
Example
• Number of crew members
• 4 (2M, 2F)
• Mission Length
• 24 days
• Minimize Mass and Volume
• Evacuation constraints
• Pr(EVAC) < 2%
• Mean CHI > 90%
49
Results (24 days, 4 crew)
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Medical Kit
Parameter Optimum Maximum
Mass (kg) 38.66 81.86
Volume (cm3) 94,527.73 201,669.01
Mean CHI (%) 91.38 95.21 
Evacuation Probability(%) 1.94 0.37
• Constraints
• Pr (EVAC) < 2%
• Mean CHI > 90%
Summary
• Two alternative optimization modules
• Answer different questions
• Multi-objectives
• Multiple constrains
• Results provide suggestions
• Compromises must be made
• Results demonstrate effectiveness of these 
optimization routines
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Conclusions
• IMM provides an evidence-based analysis of 
likely medical events and outcomes during 
space flight missions
• IMM provides the capability to assess risk
• IMM provides the capability to optimize 
medical systems
• IMM is a tool to assist in the decision making 
process
• It does not make decisions
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Questions?
